<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">compounds </span>
   <span class="font30">FIPV </span>
   <span class="font22">CLpro </span>
   <span class="font21">using </span>
   <span class="font20">antiviral </span>
   <span class="font19">cells </span>
   <span class="font19">NSC </span>
   <span class="font18">compound </span>
   <span class="font18">protease </span>
   <span class="font16">viral </span>
   <span class="font16">NSC, </span>
   <span class="font16">virus </span>
   <span class="font15">values </span>
   <span class="font15">{border-style </span>
   <span class="font15">activity </span>
   <span class="font15">candidate </span>
   <span class="font15">px;} </span>
   <span class="font15">showed </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">concentrations </span>
   <span class="font14">drug </span>
   <span class="font14">used </span>
   <span class="font14">&amp;gt; </span>
   <span class="font14">activities </span>
   <span class="font14">binding </span>
   <span class="font14">docking </span>
   <span class="font14">feline </span>
   <span class="font13">CRFK </span>
   <span class="font13">cell </span>
   <span class="font13">N/A </span>
   <span class="font13">incubated </span>
   <span class="font13">natural </span>
   <span class="font13">active </span>
   <span class="font13">assay </span>
   <span class="font13">entry </span>
   <span class="font13">infectious </span>
   <span class="font13">inhibition </span>
   <span class="font13">inhibitor </span>
   <span class="font13">CID, </span>
   <span class="font13">acid </span>
   <span class="font13">site </span>
   <span class="font13">Î¼M, </span>
   <span class="font12">analysis </span>
   <span class="font12">containing </span>
   <span class="font12">coronavirus </span>
   <span class="font12">inhibitors </span>
   <span class="font12">interactions </span>
   <span class="font12">molecular </span>
   <span class="font12">peritonitis </span>
   <span class="font12">program </span>
   <span class="font12">substrate </span>
   <span class="font12">CID </span>
   <span class="font12">CLpro. </span>
   <span class="font12">Chem. </span>
   <span class="font12">However, </span>
   <span class="font12">based </span>
   <span class="font12">different </span>
   <span class="font12">infected </span>
   <span class="font12">infection </span>
   <span class="font12">inhibit </span>
   <span class="font12">inhibitory </span>
   <span class="font12">observed </span>
   <span class="font12">results </span>
   <span class="font12">screening </span>
   <span class="font12">Med. </span>
   <span class="font12">Multimedia </span>
   <span class="font12">RNA </span>
   <span class="font12">Table </span>
   <span class="font12">cell-based </span>
   <span class="font12">component </span>
   <span class="font12">determine </span>
   <span class="font12">kinetic </span>
   <span class="font12">molecules </span>
   <span class="font12">pocket </span>
   <span class="font12">post-viral </span>
   <span class="font12">px; </span>
   <span class="font12">selected </span>
   <span class="font12">study, </span>
   <span class="font12">tested </span>
   <span class="font12">{font-family </span>
   <span class="font11">IPMA </span>
   <span class="font11">USA). </span>
   <span class="font11">activity. </span>
   <span class="font11">available </span>
   <span class="font11">catalytic </span>
   <span class="font11">cleavage </span>
   <span class="font11">concentration </span>
   <span class="font11">drugs </span>
   <span class="font11">entry, </span>
   <span class="font11">evaluated </span>
   <span class="font11">font-size </span>
   <span class="font11">hydrogen </span>
   <span class="font11">lopinavir </span>
   <span class="font11">parameters </span>
   <span class="font11">properties </span>
   <span class="font11">reaction </span>
   <span class="font11">ribavirin </span>
   <span class="font11">set </span>
   <span class="font11">small </span>
   <span class="font11">treatment </span>
   <span class="font11">version </span>
   <span class="font11">(Fig. </span>
   <span class="font11">Antiviral </span>
   <span class="font11">Carlsbad, </span>
   <span class="font11">Fig. </span>
   <span class="font11">assays. </span>
   <span class="font11">best </span>
   <span class="font11">carried </span>
   <span class="font11">contains </span>
   <span class="font11">data </span>
   <span class="font11">derivatives </span>
   <span class="font11">described </span>
   <span class="font11">double; </span>
   <span class="font11">effect </span>
   <span class="font11">following </span>
   <span class="font11">genome </span>
   <span class="font11">host </span>
   <span class="font11">including </span>
   <span class="font11">inhibited </span>
   <span class="font11">isolated </span>
   <span class="font11">lower </span>
   <span class="font11">performed </span>
   <span class="font11">plate </span>
   <span class="font11">potential </span>
   <span class="font11">protein </span>
   <span class="font11">qPCR </span>
   <span class="font11">replication </span>
   <span class="font11">residues </span>
   <span class="font11">respectively. </span>
   <span class="font11">structure </span>
   <span class="font11">study </span>
   <span class="font11">value </span>
   <span class="font11">(Pedersen, </span>
   <span class="font11">CLpro, </span>
   <span class="font11">Cys </span>
   <span class="font11">Elsevier </span>
   <span class="font11">FXa </span>
   <span class="font11">Kim </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">Therefore, </span>
   <span class="font11">USA) </span>
   <span class="font11">action </span>
   <span class="font11">analysis. </span>
   <span class="font11">approach </span>
   <span class="font11">assay. </span>
   <span class="font11">assays </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">compounds, </span>
   <span class="font11">compounds. </span>
   <span class="font11">conditions </span>
   <span class="font11">control, </span>
   <span class="font11">determined </span>
   <span class="font11">enzyme </span>
   <span class="font11">fluorogenic </span>
   <span class="font11">higher </span>
   <span class="font11">initial </span>
   <span class="font11">new </span>
   <span class="font11">novel </span>
   <span class="font11">panel </span>
   <span class="font11">presented </span>
   <span class="font11">previously </span>
   <span class="font11">prophylactic </span>
   <span class="font11">purification </span>
   <span class="font11">reduce </span>
   <span class="font11">resource </span>
   <span class="font11">scoring </span>
   <span class="font11">software </span>
   <span class="font11">solid; </span>
   <span class="font11">structural </span>
   <span class="font11">subsequently </span>
   <span class="font11">targeting </span>
   <span class="font11">virtual </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(Kuo </span>
   <span class="font11">(NSC), </span>
   <span class="font11">(Supplementary </span>
   <span class="font11">(Tokyo) </span>
   <span class="font11">-well </span>
   <span class="font11">Antibiot. </span>
   <span class="font11">C-like </span>
   <span class="font11">COVID- </span>
   <span class="font11">CoV </span>
   <span class="font11">FIP </span>
   <span class="font11">FIPV, </span>
   <span class="font11">FIPV-infected </span>
   <span class="font11">Feline </span>
   <span class="font11">LINK[alt-text] </span>
   <span class="font11">Lane </span>
   <span class="font11">MTS </span>
   <span class="font11">Ni-NTA </span>
   <span class="font11">ORFa </span>
   <span class="font11">Res. </span>
   <span class="font11">SARS </span>
   <span class="font11">Supplementary </span>
   <span class="font11">USA), </span>
   <span class="font11">according </span>
   <span class="font11">added </span>
   <span class="font11">adding </span>
   <span class="font11">amplification </span>
   <span class="font11">better </span>
   <span class="font11">biosynthetic </span>
   <span class="font11">bold </span>
   <span class="font11">centre </span>
   <span class="font11">chemical </span>
   <span class="font11">clinical </span>
   <span class="font11">combination </span>
   <span class="font11">compared </span>
   <span class="font11">courier; </span>
   <span class="font11">culture </span>
   <span class="font11">cysteine </span>
   <span class="font11">cytotoxicity </span>
   <span class="font11">demonstrated </span>
   <span class="font11">drug-like </span>
   <span class="font11">effective </span>
   <span class="font11">em; </span>
   <span class="font11">fluvirucin </span>
   <span class="font11">function </span>
   <span class="font11">functional </span>
   <span class="font11">gene </span>
   <span class="font11">generated </span>
   <span class="font11">grid </span>
   <span class="font11">group </span>
   <span class="font11">groups </span>
   <span class="font11">hepatitis </span>
   <span class="font11">high </span>
   <span class="font11">human </span>
   <span class="font11">hydrophobic </span>
   <span class="font11">included </span>
   <span class="font11">indicated </span>
   <span class="font11">influenza </span>
   <span class="font11">inoculated </span>
   <span class="font11">interaction </span>
   <span class="font11">kcat </span>
   <span class="font11">known </span>
   <span class="font11">lopinavir, </span>
   <span class="font11">modification </span>
   <span class="font11">non-covalent </span>
   <span class="font11">numbers </span>
   <span class="font11">positive </span>
   <span class="font11">pre-viral </span>
   <span class="font11">properties, </span>
   <span class="font11">protease, </span>
   <span class="font11">pt;} </span>
   <span class="font11">recombinant </span>
   <span class="font11">reduction </span>
   <span class="font11">reported </span>
   <span class="font11">reverse </span>
   <span class="font11">seven </span>
   <span class="font11">shown </span>
   <span class="font11">similar </span>
   <span class="font11">solution </span>
   <span class="font11">stictic </span>
   <span class="font11">structures </span>
   <span class="font11">tag-free </span>
   <span class="font11">target </span>
   <span class="font11">utilized </span>
   <span class="font11">Î¼M. </span>
  </p>
 </body>
</html>
